How to understand the efficacy measurements for enterovirus type 71 vaccine?

Por Li, Jing-Xin, Meng, Fan-Yue, Liang, Zhenglun, Mao, Qunying, Zhu, Feng-Cai
Publicado em 2014

Effects of Prior Influenza Exposure on Immunogenicity of Influenza Vaccine

Por Cao, Jia-Qian, Jin, Peng-Fei, Li, Jing-Xin, Zeng, Zhao-Zhun, Zhang, Li, Meng, Fan-Yue, Chu, Kai, Wang, Yuan-Yuan, Zhu, Feng-Cai
Publicado no Open Forum Infect Dis (2020)

Clinical evaluation for batch consistency of an inactivated enterovirus 71 vaccine in a large-scale phase 3 clinical trial

Por Chen, Yi-Juan, Meng, Fan-Yue, Mao, Qunying, Li, Jing-Xin, Wang, Hua, Liang, Zheng-Lun, Zhang, Yun-Tao, Gao, Fan, Chen, Qing-Hua, Hu, Yuemei, Ge, Zi-Jun, Yao, Xin, Guo, Hui-Jie, Zhu, Feng-Cai, Li, Xiu-Ling
Publicado no Hum Vaccin Immunother (2014)

Retrospective Study of the Incidence of HFMD and Seroepidemiology of Antibodies against EV71 and CoxA16 in Prenatal Women and Their Infants

Por Zhu, Feng-Cai, Liang, Zheng-Lun, Meng, Fan-Yue, Zeng, Ying, Mao, Qun-Ying, Chu, Kai, Song, Xue-Fang, Yao, Xin, Li, Jing-Xin, Ji, Hong, Zhang, Yi-Ju, Li, Liang, Pan, Hong-Xing, Xu, Ke, Dai, Wei-Ming, Zhang, Wei-Wei, Deng, Fei, Wang, Hua, Wang, Jun-Zhi
Publicado em 2012